In this current issue of the Asian Cardiovascular and Thoracic Annals (1) Niclauss et al. aimed at identifying the risk criteria leading to postoperative permanent pacemaker implantation (PPM) after aortic valve replacement (SAVR) and, more importantly, obtain a selected group of patients comparable to patients assigned to transcatheter aortic valve implantation (TAVI). The authors reviewed isolated, sutured SAVR patients operated from 2007 to 2015 with and without PPM. The incidence of PPM was 2.9% among 994 patients included. A longer hospital stay, preexisting rhythmic disorders, complex prosthetic endocarditis and complex reoperations were associated to PPM. Although these prostheses were sutured by continuous monofilament in the majority (86%), interrupted pledgeted sutures were more often used in the PPM group. In the subgroup analysis PPM incidence was 2%. Preexisting rhythmic disorders and the suturing technique were still major risk factors. Authors concluded by saying that PPM incidence depends on etiology, preexisting rhythmic disorders and suturing technique. An important topic for discussion is that a 2% incidence faces reported five to tenfold higher incidence for TAVI. Cost analysis does not imply PPM implantation when comparing TAVI with SAVR.
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Some of the issues raised by these authors for discussion are of paramount importance. First, the currently expected PPM rate after SVAR seems to be stable over time as the incidence is confirmed around 2-3%. This is an old story as the problem was outlined long ago and earlier data by Lewis et al (2) in the mideighties of the XX century already stated such PPM need after cardiac surgery. Their review of over 20,000 patients gathered from different contributions inclusive of all types of cardiac operations yielded a 2.2% incidence of PPM. Over thirty years ago these authors reported a series of 554 patients in which PPM was necessary during the same admission as the index operation in 82% of the cases for a 9.7% implant rate. This experience was related to all types of reoperations and the risk factors for PPM identified on logistic regression model were tricuspid annuloplasty, preoperative prosthetic valve infective endocarditis, advanced age and low core cardiopulmonary bypass temperature.
As this was a reoperative experience including all types of cardiac reoperations, this might of course raise the issue for discussion of heterogeneity. This and many other contributions described an expected scenario that has not changed much over time. About thirty years later, the expected PPM rate after SVAR continues to be around 2% at postoperative day 30 as highlighted by Van Mieghem et al (3) in an elegant contribution. Pacemaker is also required at around 4% beyond 30 days and stays at a linearized rate of 1% per patient/year. New bundle branch block, previous cardiac operations and severe left ventricular dysfunction predicted the need for PPM. A proportion of patients with aortic stenosis have already established conduction defects before surgery that can reach up to 60% depending on anatomical conditions (4).
In essence, when SVAR is seen as a well-established therapy for patients with aortic valve disease, PPM is required in 2% of the patients and this has not gotten worse over the years.
The second point of discussion is the currently accepted PPM rate after TAVI. It has been documented over the past decade that TAVI has higher intrinsic risks for postoperative conduction abnormalities requiring PPM, especially in those with pre-existing defects like RBBB. The recent contribution of Van Gils et al (5) analyzing TAVI patients with pre-existing RBBB yields PPM requirements of 41% ranging from 32 to 75% depending on the valve model. The indication for PPM was complete AV block in 98% of the cases. For those non-pre-existing RBBB patients, it is well known through literature that median PPM requirements may stay between 8 and 32% according to series (6, 7) . The issue is that it is taken for granted that PPM this is an intrinsic complication that has to be swiftly accepted as a minor complication. This is not the case as pacemakers do represent, like valves themselves, a new disease that carries intrinsic morbidity, especially infectious due a number of well-defined factors (8, 9) .
Although there may be some issues, like in this and many other contributions available in the literature, Niclauss et al (1) are to be commended for refreshing our memory about an often hidden issue like PPM after SAVR and currently TAVI, often taken as neglectable, but a serious problem in itself.
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